Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.63 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.63 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.61 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.50 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | TGM2 | P21980 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.48 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.48 |
| ▸ | EPHX2 | P34913 | 7/20 | 0.47 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1018094 | 1.00 | ZDHHC20 (0.63) | ZDHHC20ZDHHC2PRMT1ADRA1AMAPK1 | |
| SCHEMBL1018405 | 1.00 | ZDHHC20 (0.63) | ZDHHC20ZDHHC2PRMT1ADRA1AMAPK1 | |
| SCHEMBL707155 | 1.00 | ZDHHC20 (0.63) | ZDHHC20ZDHHC2PRMT1ADRA1AMAPK1 | |
| SCHEMBL15463341 | 1.00 | ZDHHC20 (0.63) | ZDHHC20ZDHHC2PRMT1ADRA1AMAPK1 | |
| SCHEMBL1083120 | 1.00 | ZDHHC20 (0.63) | ZDHHC20ZDHHC2PRMT1ADRA1AMAPK1 | |
| SCHEMBL1018444 | 1.00 | ZDHHC20 (0.63) | ZDHHC20ZDHHC2PRMT1ADRA1AMAPK1 | |
| SCHEMBL1015381 | 1.00 | ZDHHC20 (0.63) | ZDHHC20ZDHHC2PRMT1ADRA1AMAPK1 | |
| SCHEMBL16229524 | 1.00 | ZDHHC20 (0.63) | ZDHHC20ZDHHC2PRMT1ADRA1AMAPK1 | |
| SCHEMBL1332462 | 1.00 | ZDHHC20 (0.63) | ZDHHC20ZDHHC2PRMT1ADRA1AMAPK1 | |
| SCHEMBL1017486 | 1.00 | ZDHHC20 (0.63) | ZDHHC20ZDHHC2PRMT1ADRA1AMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4698154-A1 | MICROROBOTIC PLATFORM FOR ENDOVASCULAR EMBOLIZATION | The Chinese University of Hong Kong (HK) | 2026-02-25 | — | — | EP | disclosed |
| WO-2024217540-A1 | MICROROBOTIC PLATFORM FOR ENDOVASCULAR EMBOLIZATION | THE CHINESE UNIVERSITY OF HONG KONG (CN) | 2024-10-24 | — | — | WO | disclosed |
| US-20220395589-A1 | POLYMERIC NANOPARTICLES FOR INTRACELLULAR PROTEIN DELIVERY | THE JOHNS HOPKINS UNIVERSTY | 2022-12-15 | — | — | US | disclosed |
| US-10919926-B2 | Compound or salt thereof, natural killer T cell activator, and pharmaceutical composition | KEIO UNIVERSITY (JP) | 2021-02-16 | — | — | US | disclosed |
| US-10919926-B2 | Compound or salt thereof, natural killer T cell activator, and pharmaceutical composition | KEIO UNIVERSITY (JP) | 2021-02-16 | — | — | US | disclosed |
| CN-108467460-B | High-strength healable polyvinyl alcohol hydrogel and preparation method thereof | 长春工业大学 | 2020-07-03 | — | — | CN | disclosed |
| US-20200207798-A1 | COMPOUND OR SALT THEREOF, NATURAL KILLER T CELL ACTIVATOR, AND PHARMACEUTICAL COMPOSITION | KEIO UNIVERSITY (JP) | 2020-07-02 | — | — | US | disclosed |
| US-20200207798-A1 | COMPOUND OR SALT THEREOF, NATURAL KILLER T CELL ACTIVATOR, AND PHARMACEUTICAL COMPOSITION | KEIO UNIVERSITY (JP) | 2020-07-02 | — | — | US | disclosed |
| EP-3434684-A1 | COMPOUND OR SALT THEREOF, NATURAL KILLER T CELL ACTIVATOR, AND PHARMACEUTICAL COMPOSITION | Keio University (JP) | 2019-01-30 | — | — | EP | disclosed |
| EP-3434684-A1 | COMPOUND OR SALT THEREOF, NATURAL KILLER T CELL ACTIVATOR, AND PHARMACEUTICAL COMPOSITION | Keio University (JP) | 2019-01-30 | — | — | EP | disclosed |
| US-8709452-B2 | Synthetic bone grafts | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2014-04-29 | — | — | US | disclosed |
| US-20140083703-A1 | Triggerable Lost Circulation Material and Method of Use | HALLIBURTON ENERGY SERVICES, INC. (US) | 2014-03-27 | — | — | US | disclosed |
| US-20130177980-A1 | SYNTHETIC MATRICES FOR SELF-RENEWAL AND EXPANSION OF STEM CELLS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2013-07-11 | — | — | US | disclosed |
| US-20130017232-A1 | SYNTHETIC BONE GRAFTS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2013-01-17 | — | — | US | disclosed |
| US-20110280946-A1 | Surface-Treating Agents, Surface-Treated Powders, And Cosmetics Comprising The Same | SHISEIDO CO., LTD. (JP) | 2011-11-17 | — | — | US | disclosed |
| EP-2112179-B1 | Surface-treated powders, and cosmetics comprising the same | SHISEIDO CO LTD (JP) | 2011-04-27 | — | — | EP | disclosed |
| EP-1803750-B1 | USE OF A POLYMER FOR SURFACE-TREATING A POWDER | SHISEIDO CO LTD (JP) | 2009-12-09 | — | — | EP | disclosed |
| EP-2112179-A1 | Surface-treated powders, and cosmetics comprising the same | Shiseido Co., Ltd. (JP) | 2009-10-28 | — | — | EP | disclosed |
| US-20080081029-A1 | acrylic homopolymers or copolymers, that can provide excellent hydrophobicity to powders or cosmetics, and can improve its rinsability | SHISEIDO CO., LTD. (JP) | 2008-04-03 | — | — | US | disclosed |
| EP-1803750-A1 | SURFACE-TREATING AGENT, SURFACE-TREATED POWDER, AND COSMETIC PREPARATION CONTAINING SAME | Shiseido Company, Limited (JP) | 2007-07-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080081029-A1 | acrylic homopolymers or copolymers, that can provide excellent hydrophobicity to powders or cosmetics, and can improve its rinsability | CHRM1, H1-0, H1-2 | ZDHHC20 2867/4885ZDHHC2 3639/4885PRMT1 24/4885 |
| US-20110280946-A1 | Surface-Treating Agents, Surface-Treated Powders, And Cosmetics Comprising The Same | CHRM1, H1-0, H1-2 | ZDHHC20 2549/4885ZDHHC2 3408/4885PRMT1 21/4885 |
| US-20130017232-A1 | SYNTHETIC BONE GRAFTS | BMP2, BMP4, BMP1 | ZDHHC20 550/4885ZDHHC2 431/4885PRMT1 1690/4885 |
| US-20200207798-A1 | COMPOUND OR SALT THEREOF, NATURAL KILLER T CELL ACTIVATOR, AND PHARMACEUTICAL COMPOSITION | CD4, NFATC1, PBK | ZDHHC20 567/4885ZDHHC2 1093/4885PRMT1 2389/4885 |
| US-10919926-B2 | Compound or salt thereof, natural killer T cell activator, and pharmaceutical composition | CD4, NFATC1, PBK | ZDHHC20 722/4885ZDHHC2 1333/4885PRMT1 2109/4885 |
| US-20220395589-A1 | POLYMERIC NANOPARTICLES FOR INTRACELLULAR PROTEIN DELIVERY | LNPEP, EEA1, CLTB | ZDHHC20 2926/4885ZDHHC2 3251/4885PRMT1 2080/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.